Scientific substantiation of average annual maximum permissible level of vanadium pentoxide in ambient air as per permissible health risk

View or download the full article: 
UDC: 
613; 614
Authors: 

K.V. Chetverkina1,2, P.Z. Shur1

Organization: 

1Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, 82 Monastyrskaya St., Perm, 614045, Russian Federation
2E.A. Vagner’s Perm State Medical University, 26 Petropavlovskaya St., Perm, 614000, Russian Federation

Abstract: 

Relevance of this study is determined by the sanitary-epidemiological legislation of the Russian Federation with stipulated requirements to create hygiene standards for environmental factors ensuring their safety for people. These hygienic standards should guarantee absence of impermissible lifetime health risks.

Divanadium pentoxide is a chemical that should be mandatorily regulated in ambient air under long-term exposure due to its wide prevalence and high toxicity.

An average annual MPL for divanadium pentoxide was established by using systemic analysis of research literature and regulatory documents. According to selection results, three key epidemiological studies were taken for further analysis. They provided evidence of adverse effects produced by divanadium pentoxide on human health (the respiratory organs in particular) under chronic inhalation exposure.

When analyzing a study design, we paid special attention to description of observation groups, values of exposure and nature of its effects, adverse health outcomes caused by exposure to divanadium pentoxide as well as to a type and a value of a point of departure. We calculated a value of the total (complex) uncertainty factor in order to establish an average annual maximum permissible level of the analyzed chemical.

As a result, we suggest a scientifically substantiated (among other things, as per permissible health risk levels) average annual maximum permissible level for divanadium pentoxide, which equals 0.0001 mg/m3. This level is safe for human health under lifetime exposure. It is noteworthy that this level corresponds to ‘low uncertainty’, which indicates its high safety for human health.

Keywords: 
average annual MPL, divanadium pentoxide, ambient air, risk indicators, scientific substantiation, hygiene standard, environmental factors, uncertainty factor
Chetverkina K.V., Shur P.Z. Scientific substantiation of average annual maximum permissible level of vanadium pentoxide in ambient air as per permissible health risk. Health Risk Analysis, 2024, no. 1, pp. 18–25. DOI: 10.21668/health.risk/2024.1.02.eng
References: 
  1. Xi W.-S., Song Z.-M., Chen Z., Chen N., Yan G.-H., Gao Y., Cao A., Liu Y., Wang H. Short-term and long-term toxicological effects of vanadium dioxide nanoparticles on A549 cells. Environ. Sci.: Nano, 2019, vol. 6, no. 2, pp. 565–579.
  2. Fan N.-C., Huang H.-Y., Wang S.-L., Tseng Y.-L., Chang-Chien J., Tsai H.-J., Yao T.-C. Association of exposure to environmental vanadium and manganese with lung function among young children: A population-based study. Ecotoxicol. Environ. Saf., 2023, vol. 264, pp. 115430. DOI: 10.1016/j.ecoenv.2023.115430
  3. Lewis C.E. The biological effects of vanadium. II. The signs and symptoms of occupational vanadium exposure. AMA Arch. Ind. Health, 1959, vol. 19, no. 5, pp. 497–503.
  4. Xi W.S., Li J.-B., Liu Y.-Y., Wu H., Cao A., Wang H. Cytotoxicity and genotoxicity of low-dose vanadium dioxide nanoparticles to lung cells following long-term exposure. Toxicology, 2021, vol. 459, pp. 152859. DOI: 10.1016/j.tox.2021.152859
  5. He X., Jarrell Z.R., Liang Y., Smith M.R., Orr M.L., Marts L., Go Y.-M., Jones D.P. Vana-dium pentoxide induced oxidative stress and cellular senescence in human lung fibroblasts. Redox Biol., 2022, vol. 55, pp. 102409. DOI: 10.1016/j.redox.2022.102409
  6. Tu W., Xiao X., Lu J., Liu X., Wang E., Yuan R., Wan R., Shen Y. [et al.]. Vanadium exposure exacerbates allergic airway inflammation and remodeling through triggering reactive oxidative stress. Front. Immunol., 2022, vol. 13, pp. 1099509. DOI: 10.3389/fimmu.2022.1099509
  7. Xi W.-S., Tang H., Liu Y.-Y., Liu C.-Y., Gao Y., Cao A., Liu Y., Chen Z., Wang H. Cyto-toxicity of vanadium oxide nanoparticles and titanium dioxide-coated vanadium oxide nanoparticles to human lung cells. J. Appl. Toxicol., 2020, vol. 40, no. 5, pp. 567–577. DOI: 10.1002/jat.3926
  8. Irsigler G.B., Visser P.J., Spangenberg P.A. Asthma and chemical bronchitis in vanadium plant worker. Am. J. Ind. Med., 1999, vol. 35, no. 4, pp. 366–374. DOI: 10.1002/(sici)1097-0274(199904)35:43.0.co;2-n
  9. Rondini E.A., Walters D.M., Bauer A.K. Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner. Part. Fibre Toxicol., 2010, vol. 7, pp. 9. Available at: http://www.particleandfibretoxicology.com/content/pdf/1743-8977-7-9.pdf (January 18, 2024).
  10. Turpin E.A., Antao-Menezes A., Cesta M.F., Mangum J.B., Wallace D.G., Bermudez E., Bonner J.C. Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide. Respir. Res., 2010, vol. 11, no. 1, pp. 20. DOI: 10.1186/1465-9921-11-20
  11. Cervantes-Yépez S., López-Zepeda L.S., Fortoul T.I. Vanadium inhalation induces retinal Müller glial cell (MGC) alterations in a murine model. Cutan. Ocul. Toxicol., 2018, vol. 37, no. 2, pp. 200–206. DOI: 10.1080/15569527.2017.1392560
  12. Shalabayeva D.M., Beisenova R.R., Khanturin M.R. The toxic effects of vanadium ions on organisms. Veles, 2016, no. 2–1 (32), pp. 62–65.
  13. Mounasamy V., Mani G.K., Sukumaran S., Ponnusamy D., Tsuchiya K., Prasad A.K., Madanagurusamy S. [et al.]. Vanadium oxide nanoparticles for dimethylamine vapour detection. 2018 International Symposium on Micro-NanoMechatronics and Human Science (MHS), Nagoya, Japan, 2018, pp. 1–5. DOI: 10.1109/MHS.2018.8886979
  14. Lashari A., Kazi T.G., Afridi H.I., Baig J.A., Arain M.B., Lashari A.A. Evaluate the Work-Related Exposure of Vanadium on Scalp Hair Samples of Outdoor and Administrative Workers of Oil Drilling Field: Related Health Risks. Biol. Trace Elem. Res., 2024, pp. 1–7. DOI: 10.1007/s12011-024-04101-y
  15. Test No. 405: Acute Eye Irritation/Corrosion. In book: OECD Guidelines for the Testing of Chemicals, Section 4. Paris, OECD Publishing, 2023, 13 p. DOI: 10.1787/9789264185333-en
  16. National Toxicology Program. NTP toxicology and carcinogenesis studies of vanadium pentoxide (CAS No. 1314-62-1) in F344/N rats and B6C3F1 mice (inhalation). Natl Toxicol. Pro-gram Tech. Rep. Ser., 2002, no. 507, pp. 1–343.
  17. Rojas-Lemus M., Bizarro-Nevares P., López-Valde N., González-Villalva A., Guerrero-Palomo G., Cervantes-Valencia M.E., Tavera-Cabrera O., Rivera-Fernández N. [et al.]. Oxidative stress and Vanadium. In book: Genotoxicity and Mutagenicity – Mechanisms and Test Methods. IntechOpen, 2021, Chapter 6, pp. 93–110. DOI: 10.5772/intechopen.90861
  18. Kiviluoto M. Observations on the lungs of vanadium workers. Br. J. Ind. Med., 1980, vol. 37, no. 4, pp. 363–366. DOI: 10.1136/oem.37.4.363
  19. Kiviluoto M. A clinical study of occupational exposure to vanadium pentoxide dust: Aca-demic thesis. Acta Universitatis Ouluensis. Series D Medica n. 72. – Medica Publica n. 2. Oulu, Finland, 1981.
  20. Kiviluoto M., Pyy L., Pakarinen A. Clinical laboratory results of vanadium-exposed work-ers. Arch. Environ. Health, 1981, vol. 36, no. 3, pp. 109–113. DOI: 10.1080/00039896.1981.10667613
Received: 
15.01.2023
Approved: 
12.03.2024
Accepted for publication: 
14.03.2024

You are here